Fig. 4

Representative reversal effect of idarucizumab (IDZ) on the anticoagulant effects induced by DAB (1 µM) and DABG (1 µM) assessed by PT (A), aPTT (B), TT (C) using individual plasma samples (n = 5). Dotted line indicates the baseline value of each test. *, P < 0.05; **, P < 0.01; ***, P < 0.001.